IFP Advisors’s Ultralife ULBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$37.9K Buy
6,000
+3,000
+100% +$20.2K ﹤0.01% 2571
2026
Q1
$19.6K Sell
3,000
-5,600
-65% -$34.8K ﹤0.01% 2791
2025
Q4
$49.2K Sell
8,600
-1
-0% -$6 ﹤0.01% 2196
2025
Q3
$58.7K Buy
8,601
+36
+0.4% +$273 ﹤0.01% 1999
2025
Q2
$77.6K Sell
8,565
-5,635
-40% -$33.4K ﹤0.01% 1793
2025
Q1
$76.4K Buy
14,200
+2,800
+25% +$19K ﹤0.01% 1684
2024
Q4
$84.9K Buy
+11,400
New +$93.7K ﹤0.01% 1555
2023
Q3
Sell
-400
Closed -$1.94K 3559
2023
Q2
$1.94K Buy
+400
New +$1.74K ﹤0.01% 2892

Other funds holding ULBI

IFP Advisors's ULBI Position: Q2 2026 in Review

IFP Advisors increased its Ultralife (ULBI) stake by 100% in Q2 2026, buying an estimated $20.2K and bringing the position to 6,000 shares worth $37.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2571.

IFP Advisors first reported a position in ULBI in Q2 2023 and has held it in 8 quarters since. The position peaked at $84.9K in Q4 2024. 52 funds tracked by Wall St. Rank hold ULBI as of Q2 2026.

  • IFP Advisors held 6,000 shares of Ultralife worth $37.9K as of Q2 2026.
  • IFP Advisors bought 3,000 Ultralife shares in Q2 2026, an estimated $20.2K.
  • Ultralife made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2571 holding.
  • IFP Advisors first reported a position in Ultralife in Q2 2023 and has held it in 8 quarters since.
  • IFP Advisors's Ultralife position peaked at $84.9K in Q4 2024.
  • 52 funds tracked by Wall St. Rank held Ultralife as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.